-Search query
-Search result
Showing 1 - 50 of 122 items for (author: walls & ac)
EMDB-26378:
Cryo-EM structure of PDF-2180 Spike glycoprotein
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-32686:
Structure of NeoCOV RBD binding to Bat37 ACE2
Method: single particle / : Cao L, Wang X, Tortorici MA, Veesler D
EMDB-32693:
Structure of PDF-2180-COV RBD binding to Bat37 ACE2
Method: single particle / : Cao L, Wang X, Tortorici MA, Veesler D
EMDB-27779:
Structure of the SARS-CoV-2 spike glycoprotein S2 subunit
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-8dya:
Structure of the SARS-CoV-2 spike glycoprotein S2 subunit
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-28558:
SARS-CoV-2 BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment (local refinement of the RBD and S2X324)
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-28559:
SARS-CoV-2 Omicron BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-8erq:
SARS-CoV-2 BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment (local refinement of the RBD and S2X324)
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-8err:
SARS-CoV-2 Omicron BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-26727:
Structure of the human coronavirus CCoV-HuPn-2018 spike glycoprotein with domain 0 in the proximal conformation
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-26729:
CCoV-HuPn-2018 S in the proximal conformation (local refinement of domain 0)
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-26730:
Structure of the human coronavirus CCoV-HuPn-2018 spike glycoprotein with domain 0 in the swung out conformation
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-26731:
CCoV-HuPn-2018 S in the swung out conformation (local refinement of domain 0)
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7us6:
Structure of the human coronavirus CCoV-HuPn-2018 spike glycoprotein with domain 0 in the proximal conformation
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7us9:
CCoV-HuPn-2018 S in the proximal conformation (local refinement of domain 0)
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7usa:
Structure of the human coronavirus CCoV-HuPn-2018 spike glycoprotein with domain 0 in the swung out conformation
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7usb:
CCoV-HuPn-2018 S in the swung out conformation (local refinement of domain 0)
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-24678:
SARS-CoV-2 S/S2M11/SNAP1 Global Refinement
Method: single particle / : Dang HV, Veesler D
EMDB-24679:
SARS-CoV-2 S/S2M11/SNAP1 Local Refinement
Method: single particle / : Dang HV, Veesler D
EMDB-26507:
SARS-CoV-2 spike in complex with Multivalent miniprotein inhibitor FUS231-P24 (2RBDs open)
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-26508:
SARS-CoV-2 spike in complex with multivalent miniprotein inhibitor FUS231-P24 (3RBDs open)
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-26509:
SARS-CoV-2 spike in complex with multivalent miniprotein inhibitor FUS31-G10 (2RBDs open)
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-26510:
SARS-CoV-2 spike in complex with multivalent miniprotein inhibitor FUS31-G10 (3RBDs open)
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-26511:
SARS-CoV-2 spike in complex with AHB2-2GS-SB175 (local refinement of the RBD and AHB2)
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-26512:
SARS-CoV-2 spike in complex with AHB2-2GS-SB175
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-25990:
SARS-CoV-2 S B.1.1.529 Omicron variant (RBD + S309 Local Refinement)
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25991:
SARS-CoV-2 S NTD B.1.1.529 Omicron variant + S309 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25992:
SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25993:
SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement (Two-open RBDs and one-closed RBD)
Method: single particle / : McCallum M, Veesler D
EMDB-25785:
SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (three receptor-binding domains open)
Method: single particle / : Park YJ, Veesler D
EMDB-25783:
SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (local refinement of the RBD and S2K146)
Method: single particle / : Park YJ, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25784:
SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (two receptor-binding domains open)
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-7tas:
SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (local refinement of the RBD and S2K146)
Method: single particle / : Park YJ, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7tat:
SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (two receptor-binding domains open)
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-25263:
SARS-CoV-2 S B.1.617.2 delta variant + S2M11 + S2L20 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25264:
SARS-CoV-2 S NTD B.1.617.2 delta variant + S2L20 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25265:
SARS-CoV-2 S B.1.617.1 kappa variant + S309 + S2L20 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25266:
SARS-CoV-2 S RBD B.1.617.1 kappa variant S309 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25267:
SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25268:
SARS-CoV-2 S B.1.617.1 kappa variant + S2X303 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-25269:
SARS-CoV-2 S NTD B.1.617.1 kappa variant S2X303 Local Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-24607:
SARS-CoV-2 spike in complex with the S2X58 neutralizing antibody Fab fragment (two receptor-binding domains open)
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-24608:
SARS-CoV-2 spike in complex with the S2X58 neutralizing antibody Fab fragment (three receptor-binding domains open)
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-24533:
SARS-CoV-2 spike protein bound to the S2P6 and S2M11 Fab fragments
Method: single particle / : Sauer MM, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-24347:
SARS-CoV-2 S glycoprotein in complex with S2X259 Fab
Method: single particle / : Veesler D, Tortorici MA, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-24365:
SARS-CoV-2 S bound to S2X259 Fab (local refinement of the RBD/S2X259 variable domains)
Method: single particle / : Veesler D, Tortorici MA, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7ra8:
SARS-CoV-2 S glycoprotein in complex with S2X259 Fab
Method: single particle / : Veesler D, Tortorici MA, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7ral:
SARS-CoV-2 S bound to S2X259 Fab (local refinement of the RBD/S2X259 variable domains)
Method: single particle / : Veesler D, Tortorici MA, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-24299:
SARS-CoV-2 spike in complex with the S2D106 neutralizing antibody Fab fragment (local refinement of the RBD and S2D106)
Method: single particle / : Park YJ, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-24300:
SARS-CoV-2 spike in complex with the S2D106 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Veesler D
Pages: